Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Reversal of Anticoagulant Effect of Dabigatran and Rivaroxaban Ex-Vivo
NCT01210755Phase 4Completed
- Sponsor
- CHU Grenoble Alpes
- Start
- Nov 2010
- Primary completion
- Mar 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of rivaroxaban, dabigatran in venous thromboembolism (VTE), sponsored by CHU Grenoble Alpes. Started Nov 2010; status: completed.
02
Drugs
rivaroxabandabigatran
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on NCT01210755.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01210755.